Neumora's Stock Plummets After Depression Drug Trial Fails
Neumora Therapeutics Inc.'s shares drop after their depression drug's final-stage trial failure. Discover what this means for investors and the company's future.
Neumora Therapeutics Inc.'s share price fell significantly after a failed final-stage trial of their depression drug.